Literature DB >> 34091747

Renal manifestations in children with neurofibromatosis type 1.

Binnaz Celik1, Ozlem Yuksel Aksoy2, Funda Bastug3, Hatice Gamze Poyrazoglu4.   

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurocutaneous syndrome affecting various parts of the body, including the renovascular and urinary systems. We evaluated the renovascular, urinary, glomerular, and tubular functions of children with NF1. We compared blood pressures, urinary findings, and renal glomerular and tubular functions in children with NF1 with those of a healthy age- and gender-matched control group. We evaluated 46 NF1 patients and 33 healthy controls. The mean ages of the NF1 group (female/male: 20/26) and the control group (female/male: 15/18) were 10.1 ± 4.6 and 10.6 ± 4.3 years respectively. Six NF1 patients were hypertensive. The mean blood pressures of the NF1 group were significantly higher than those of the control group. Renal artery stenosis was detected in one NF1 patient. Urinary tract anomalies were evident in 21.7% of NF1 but only 9% of control subjects. The mean estimated glomerular filtration rate (eGFR) of the NF1 group was significantly lower than that of the control group. Six NF1 patients evidenced eGFRs < 90 mL/min. In the NF1 group, tubular phosphorus reabsorption was significantly lower and uric acid excretion significantly higher than in the control group.
Conclusion: Hypertension, urinary tract anomalies, and impaired renal function were more common in NF1 patients than healthy controls. Regular blood pressure measurements and evaluation of urinary tract and kidney function are essential for NF1 patients. What is Known: • NF1 is most commonly associated with systemic hypertension due to renal artery vasculopathy and the development of a pheochromocytoma. • Hydronephrosis and bladder involvement have been documented in NF1. What is New: • Renal glomerular and tubular functions may be affected in NF1.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Children; Neurofibromatosis type 1; Renal manifestations; eGFR

Mesh:

Year:  2021        PMID: 34091747     DOI: 10.1007/s00431-021-04144-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

Review 1.  Focal segmental glomerular sclerosis in a patient with neurofibromatosis type I.

Authors:  Michael S Gersch; Zvi Talor
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

2.  Focal and segmental glomerulosclerosis and von Recklinghausen's neurofibromatosis: coincidental or associated?

Authors:  Faissal Tarrass
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-05

Review 3.  A case of membranous glomerulonephritis associated with Recklinghausen's neurofibromatosis.

Authors:  T Tóth; C Trinn; L Simon; J Nagy
Journal:  Clin Nephrol       Date:  1996-04       Impact factor: 0.975

4.  [Secondary glomerulonephritis in neurofibromatosis type 1. Two case reports].

Authors:  A Orera; S Lacarra; L Fernández; N Gómez; M F Slon; J Manrique
Journal:  An Sist Sanit Navar       Date:  2019-12-05       Impact factor: 0.829

5.  Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?

Authors:  Julien Van-Gils; Jérôme Harambat; Charlotte Jubert; Dominique Vidaud; Brigitte Llanas; Yves Perel; Didier Lacombe; Cyril Goizet
Journal:  Eur J Med Genet       Date:  2014-09-16       Impact factor: 2.708

6.  von Recklinghausen's neurofibromatosis associated with membranous glomerulonephritis.

Authors:  Muzafar M Wani; Abdul R Reshi; Khursheed A Banday; Mohd S Najar
Journal:  Saudi Med J       Date:  2006-04       Impact factor: 1.484

Review 7.  Neurofibromatosis type 1: a multidisciplinary approach to care.

Authors:  Angela C Hirbe; David H Gutmann
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

8.  THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1.

Authors:  Fujun Lin; Dan Zhang; Juan Chang; Xuanli Tang; Wenbin Guan; Gengru Jiang; Chun Zhu; Fan Bian
Journal:  Eur J Med Genet       Date:  2017-10-25       Impact factor: 2.708

Review 9.  The Diagnosis and Management of Neurofibromatosis Type 1.

Authors:  K Ina Ly; Jaishri O Blakeley
Journal:  Med Clin North Am       Date:  2019-11       Impact factor: 5.456

10.  Anuric acute kidney injury in neurofibromatosis 1.

Authors:  Usman Khan; Rishi Razdan; Mark A Perazella
Journal:  Am J Kidney Dis       Date:  2012-11-21       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.